Ascend Wellness Holdings (AAWH) Asset Utilization Ratio (2021 - 2026)
Ascend Wellness Holdings' (AAWH) quarterly Asset Utilization Ratio came in at 0.55 in Q1 2026, down 8.67% year-on-year from 0.6 in Q1 2025, and down 50.1% quarter-over-quarter from 1.1 in Q4 2025.
Ascend Wellness Holdings (AAWH) Asset Utilization Ratio (2021 - 2026) Analysis & Trends
Ascend Wellness Holdings' Asset Utilization Ratio history runs 6 years deep, the most recent figure standing at 0.55 for Q1 2026.
- On a quarterly basis, Asset Utilization Ratio fell 8.67% year-over-year to 0.55 in Q1 2026; TTM through Mar 2026 was 0.55, a 8.67% decrease from a year earlier, with the FY2025 full-year figure at 0.55, down 10.29% from the prior year.
- Asset Utilization Ratio declined to 0.55 in Q1 2026 per AAWH's latest filing, from 1.1 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 1.14 in Q3 2025 and bottomed at 0.46 in Q3 2022.
- The 5-year median for Asset Utilization Ratio is 0.57 (2023), against an average of 0.61.
- Across the five-year window, Asset Utilization Ratio surged 84.11% in 2025 and slipped 8.67% in 2026, its largest moves.
- Year by year, Asset Utilization Ratio stood at 0.47 in 2022, then rose by 20.19% to 0.57 in 2023, then advanced by 10.18% to 0.63 in 2024, then jumped by 76.27% to 1.1 in 2025, then sank by 50.1% to 0.55 in 2026.
- Per Business Quant, the three latest AAWH Asset Utilization Ratio figures stand at 0.55 (Q1 2026), 1.1 (Q4 2025), and 1.14 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 0.43 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 0.62 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 0.46 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 0.43 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 0.39 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 0.65 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 0.37 |
| 10 | Ascend Wellness Holdings | 83.00 Mn | 22.91 Mn | 44.88 Mn | 0.55 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.55 |
| Dec 31, 2025 | 1.10 |
| Sep 30, 2025 | 1.14 |
| Jun 30, 2025 | 0.59 |
| Mar 31, 2025 | 0.60 |
| Dec 31, 2024 | 0.63 |
| Sep 30, 2024 | 0.62 |
| Jun 30, 2024 | 0.61 |
| Mar 31, 2024 | 0.59 |
| Dec 31, 2023 | 0.57 |
| Sep 30, 2023 | 0.54 |
| Jun 30, 2023 | 0.52 |
| Mar 31, 2023 | 0.50 |
| Dec 31, 2022 | 0.47 |
| Sep 30, 2022 | 0.46 |
| Jun 30, 2022 | 0.47 |
| Mar 31, 2022 | 0.49 |
| Dec 31, 2021 | 0.46 |
| Sep 30, 2021 | 0.46 |
| Jun 30, 2021 | 0.46 |